All In Biotech

Free tool

FAERS Monitor: Cyclophosphamide

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203856 or its brand name (Cyclophosphamide, Cyclophosphamide). Reports on generic versions are filed under their own applications.

Reports

179,391

Serious

172,655

96% of reports

Hospitalization

64,821

Death reported

36,268

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use16,826
  • febrile neutropenia14,787
  • drug ineffective10,788
  • neutropenia10,780
  • pyrexia9,368
  • disease progression8,229
  • pneumonia6,779
  • thrombocytopenia6,679
  • product use in unapproved indication6,563
  • nausea6,354
  • anaemia6,286
  • sepsis5,803
  • diarrhoea5,568
  • death5,287
  • vomiting5,000

Reports by year received

View as table
YearReports
20041,541
20051,760
20061,662
20071,990
20082,643
20093,104
20103,472
20115,665
20125,198
20133,764
20144,002
20155,802
20165,819
20177,870
201811,680
201912,218
202012,590
202112,754
202215,807
202317,132
202417,177
202515,538
202610,200

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,874,768 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal14,78733.332.8361,655
neutropeniaSignal10,78010.09.881,008
disease progressionSignal8,2298.78.552,382
thrombocytopeniaSignal6,6797.47.234,842
sepsisSignal5,8036.46.225,083
anaemiaSignal6,2864.03.913,581
pyrexiaSignal9,3683.23.214,305
product use in unapproved indicationSignal6,5633.23.19,555
pneumoniaSignal6,7792.52.45,986
off label useSignal16,8262.32.212,338
vomiting5,0001.21.2252
diarrhoea5,5681.01.01
drug ineffective10,7881.00.920
nausea6,3540.90.924
death5,2870.70.7608

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.